Mechanisms of RANKL delivery to the osteoclast precursor cell surface

Area of Science:

• Bone Biology
• Cell Signaling
• Osteoclastogenesis

Background:

• Receptor Activator of Nuclear Factor kappa-B Ligand (RANKL) is essential for osteoclast differentiation.
• The transmembrane form of RANKL plays a significant role in osteoclast induction in vivo.
• Osteocytes and osteoblasts regulate RANKL availability through complexation with Osteoprotegerin (OPG).

Purpose of the Study:

• To highlight the importance of transmembrane RANKL in osteoclast formation.
• To identify the cellular mechanisms by which osteocytes deliver RANKL to osteoclast precursors.
• To underscore the knowledge gap in understanding RANKL transport from osteocytes to osteoclast precursors.

Main Methods:

• Review of recent studies on RANKL biosynthesis and function.
• Analysis of RANKL trafficking pathways involving OPG and lysosomes.
• Discussion of the cell surface delivery of transmembrane RANKL.

Main Results:

• Most newly synthesized RANKL in osteoblasts/osteocytes forms a complex with OPG and is lysosomally degraded.
• Only a small fraction of RANKL not complexed with OPG reaches the cell surface as transmembrane RANKL.
• Transmembrane RANKL on osteoclast precursors stimulates RANK, initiating downstream signaling for osteoclast activation.

Conclusions:

• Osteocyte cell surface RANKL levels are critical for supporting mature osteoclast formation.
• The precise mechanism for delivering transmembrane RANKL from embedded osteocytes to osteoclast precursors in the bone marrow cavity remains unclear.
• Further research is necessary to elucidate the transport mechanisms of RANKL in bone remodeling.